Form D · Biotechnology

Saccharo, Inc.

Oakland, CA · CIK 0001943550

Offering snapshot reported Sep 8, 2023 · SEC filing

Reported sold
$7.38M
Offering amount: $10.6M
Investors reported
45
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 10, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.69M$7.38MAug 22, 2022: $6,676,993.00Aug 22, 2022Sep 8, 2023: $7,377,002.00Sep 8, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,676,993 → $7,377,002
  • Reported investors40 → 45

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 8, 2023Amendment$7,377,002$700,009vs Aug 22, 202245SEC filing
Aug 22, 2022Initial$6,676,993No comparison40SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-456415

Source: Form D, filed Sep 8, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Margaret Kim Executive
Sheryl A. Martin Moe, Ph.D. Director, Executive
Gregory R. Moe, Ph.D. Director
Winnie H. Wan, Ph.D. Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6401 Chelton Drive
Oakland, CA, 94611